FDA and NIH Joint Public Meeting on Advancing Smoking Cessation Priorities REGISTRATION IS OPEN On Monday, October 21, from 9 a.m. to 4:30 p.m. EDT, the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) will host a joint public meeting entitled, “Advancing Smoking Cessation: FDA and NIH Priorities.” The focus […]

Advancing Smoking Cessation: FDA and NIH Priorities Attend the joint public meeting hosted by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). Goals and Objectives:  This public meeting will address the need for novel smoking cessation products to help individuals of all ages, including underserved and vulnerable populations, stop smoking. […]

Join January 16 FDA Grand Rounds - The PATH from Data to Action: Key Findings from the Population Assessment of Tobacco and Health Study to Inform FDA’s Regulatory Activities The Population Assessment of Tobacco and Health (PATH) Study, a national, longitudinal cohort study of tobacco use and health in the United States, is one of […]

January 30 | Demystifying Medications for Substance Use Disorder @ 2 p.m. ET Save the date for this upcoming event! https://www.samhsa.gov/about/digital-toolkits/substance-use-disorder-treatment-month

"What’s Emergent in Emerging Adult Recovery Support Services Research?" Forum Series (Part 1) "Emerging adults aged 16–25 face heightened risks of opioid use disorder (OUD) and fentanyl-related overdoses. Although medications for opioid use disorder (MOUD) are effective for long-term management, emerging adults often encounter significant challenges, including unmet needs in employment, housing, and social support. […]

NABR Webinar: “The FY 2024 USDA Oversight Process” Please join us on Jan. 14, 2025, at 12:30 p.m. EST for the first of NABR’s 2025 Webinar series, “The FY 2024 USDA Oversight Process.” Each year NABR obtains information from the USDA’s Animal Care Inspection System database using the Public Search Tool to review the inspection results […]

Vermont Center on Behavior & Health Monthly Lecture Series Michael Amlung, PhD Associate Professor in Applied Behavioral Science at University of Kansas Wednesday, February 19, 2025, 12-1 pm UVMMC Davis Auditorium Application of behavioral economics to investigate contextual influences on alcohol and cannabis use Registration Link:  https://uvmcom.zoom.us/webinar/register/WN_nDjyfnScRCq_ZXmfEwcSyA#/registration  Dr. Michael Amlung is an Associate Professor and […]

"What’s Emergent in Emerging Adult Recovery Support Services Research?" Forum Series (Part 2) "Emerging adults aged 16–25 face heightened risks of opioid use disorder (OUD) and fentanyl-related overdoses. Although medications for opioid use disorder (MOUD) are effective for long-term management, emerging adults often encounter significant challenges, including unmet needs in employment, housing, and social support. […]

"What’s Emergent in Emerging Adult Recovery Support Services Research?" Forum Series (Part 3) "Emerging adults aged 16–25 face heightened risks of opioid use disorder (OUD) and fentanyl-related overdoses. Although medications for opioid use disorder (MOUD) are effective for long-term management, emerging adults often encounter significant challenges, including unmet needs in employment, housing, and social support. […]

ISAJE Publishing Addiction Science Collaborative Webinar Please join The College on Problems of Drug Dependence (CPDD) and the International Society of Addiction Journal Editors (ISAJE) for an insightful collaborative webinar designed to help researchers navigate the complexities of academic publishing. Adam J. Gordon, M.D., MPH, FACP, DFASAM Journal Metrics and Choosing the Right Journal Editor-in-Chief, […]

Global Innovation Day for Addiction Therapeutics Addiction is a major public health issue affecting millions worldwide. Innovative solutions are urgently needed to combat this crisis, reduce its impact, and save lives. The World Innovation Day for Addiction Therapeutics serves as a platform for fostering collaboration between academia, health sector, regulatory agencies, and industry, driving innovation, […]